Markets › United States › NAS › LUCD

Lucid Diagnostics Inc

NAS:LUCDHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$0.3161−16.24%LiveIn session · ≈ AED 1.16 · Market cap $64.25M · Next earnings Wed 11 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	−17.0%	−858.6%	−249.2%	−90.2%	−60.3%	—	—
Operating margin	—	−5,483.8%	−14,899.5%	−1,996.8%	−1,059.6%	−1,054.8%	−1,054.8%	+0.0 pts
Net margin	—	−5,615.6%	−14,899.5%	−2,169.1%	−1,047.6%	−1,232.7%	−1,232.7%	+0.0 pts
EBITDA margin	—	−5,483.0%	−14,383.8%	−2,049.1%	−1,020.2%	−1,213.7%	—	—
Return on equity	61.3%	−51.3%	−243.7%	2,278.9%	−844.5%	−530.4%	−530.4%	+0.0 pts
Return on assets	−377.2%	−47.6%	−172.8%	−193.1%	−148.2%	−143.4%	−143.4%	+0.0 pts
Return on capital employed	61.3%	−50.1%	−233.2%	2,295.5%	−640.4%	−418.4%	—	—
Debt / equity	0.0×	0.0×	0.1×	−6.6×	3.9×	2.4×	2.4×	+0.0%
Debt / assets	0.0%	0.0%	6.1%	55.9%	69.2%	63.8%	—	—
Interest coverage	0.0×	−41.6×	−7,021.4×	−116.5×	−1,771.2×	−2,256.4×	—	—
Current ratio	0.1×	13.5×	2.9×	0.8×	1.1×	1.3×	1.3×	+0.0%
Quick ratio	0.0×	13.3×	2.9×	0.7×	1.1×	1.3×	—	—
Cash ratio	0.0×	12.6×	2.7×	0.6×	1.0×	1.2×	1.2×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.1×	0.1×	0.1×	—	—
Inventory turnover	0.0×	1.2×	32.6×	30.5×	24.2×	21.4×	—	—
Receivables turnover	—	2.5×	22.2×	54.0×	10.7×	7.3×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—